See also this year's filing and all EDGAR filings for this company.
PDF Report 0000722104_2011_Savient_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0000722104')"} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0000722104, Savient Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | LiabilitiesNoncurrent | 0 |
| 1 | LiabilitiesCurrent | 18,052,000 |
| 2 | remainder_Liabilities | 0 |
| 3 | AssetsCurrent | 71,325,000 |
| 4 | AssetsNoncurrent | 1,284,000 |
| 5 | PropertyPlantAndEquipmentNet | 809,000 |
| 6 | Goodwill | 0 |
| 7 | remainder_Assets | 4,200,000 |
| 8 | GeneralAndAdministrativeExpense | 24,981,000 |
| 9 | ResearchAndDevelopmentExpense | 32,358,000 |
| 10 | remainder_Expenses | 2,664,000 |
| 11 | remainder_Revenues | 4,028,000 |
| 12 | remainder_NetIncome | -17,134,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Liabilities | 18,052,000 |
| 1 | Assets | 77,618,000 |
| 2 | Expenses | 60,003,000 |
| 3 | Revenues | 4,028,000 |
| 4 | StockholdersEquity | 59,566,000 |
| 5 | NetIncome | -73,109,000 |
| 6 | ComprehensiveNetIncome | -73,109,000 |
| 7 | BaseVar | 88,417,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.178 |
| 9 | EconomicCapitalRatio | 1.02 |
Edgar->Model Mapping
Feature Distribution
